E1	Condition:T1 Name:T24
E2	Eq-Comparison:T2 Operator:T27 Temporal-Unit:T28 Value:T50
E4	Drug:T4 Name:T29
E5	Procedure:T5 Temporality:E3 Duration:E6
E6	Eq-Comparison:T6 Operator:T30 Value:T31 Temporal-Unit:T32
E7	Condition:T7 Name:T53
E8	Condition:T8 Name:T33
E9	Condition:T9 Name:T34
E10	Condition:T10 Name:T35 Temporality:E11
E11	Eq-Comparison:T11 Temporal-Period:T36
E12	Eq-Comparison:T12 Temporal-Period:T37
E13	Procedure:T13 Name:T38 Temporality:E12
E14	Procedure:T14 Name:T39
E15	Eq-Comparison:T15 Temporal-Period:T55
E16	Other:T16 Is-Other:E17
E17	Procedure:T17 Name:T40 Temporality:E15
E24	Age:T51 Numeric-Filter:E2
E3	Eq-Comparison:T3 Temporal-Period:T52
E25	Modifier:T54 Modifies:T33
E18	Observation:T18 Name:T19 Numeric-Filter:E19
E19	Eq-Comparison:T20 Operator:T21 Value:T22 Unit:T23 Per:T41
E20	Allergy:T42 Name:E21
E21	Drug:T43 Name:T44
E22	Condition:T45 Name:T46
E23	Drug:T47 Name:T48
E26	Contraindication:T49 Contraindicates:E23
T1	Condition 25 39	Postmenopausal
T2	Eq-Comparison 55 63	>50-year
T4	Drug 79 88	Denosumab
T5	Procedure 89 98	treatment
T6	Eq-Comparison 99 108	≥ 2 years
T7	Condition 116 128	osteoporosis
T8	Condition 164 176	osteoporosis
T9	Condition 182 204	metabolic bone disease
T10	Condition 210 216	cancer
T11	Eq-Comparison 217 224	history
T12	Eq-Comparison 230 240	continuous
T13	Procedure 241 256	steroid therapy
T14	Procedure 262 289	hormone replacement therapy
T15	Eq-Comparison 295 299	ever
T16	Other 309 314	other
T17	Procedure 323 348	anti-resorptive treatment
T24	Condition-Name 25 39	Postmenopausal
T25	Life-Stage-And-Gender 40 45	women
T26	Life-Stage-And-Gender 51 54	Men
T27	Eq-Operator 55 56	>
T28	Eq-Temporal-Unit 59 63	year
T29	Drug-Name 79 88	Denosumab
T30	Eq-Operator 99 100	≥
T31	Eq-Value 101 102	2
T32	Eq-Temporal-Unit 103 108	years
T33	Condition-Name 164 176	osteoporosis
T34	Condition-Name 182 204	metabolic bone disease
T35	Condition-Name 210 216	cancer
T36	Eq-Temporal-Period 217 224	history
T37	Eq-Temporal-Period 230 240	continuous
T38	Procedure-Name 241 256	steroid therapy
T39	Procedure-Name 262 289	hormone replacement therapy
T40	Procedure-Name 323 348	anti-resorptive treatment
T50	Eq-Value 56 58	50
T51	Age 64 67	old
T3	Eq-Comparison 73 78	After
T52	Eq-Temporal-Period 73 78	After
T53	Condition-Name 116 128	osteoporosis
T54	Modifier 154 163	secondary
T55	Eq-Temporal-Period 295 299	ever
T18	Observation 354 390	estimated Glomerular filtration rate
T19	Observation-Name 354 390	estimated Glomerular filtration rate
T20	Eq-Comparison 391 402	< 35 mL/min
T21	Eq-Operator 391 392	<
T22	Eq-Value 393 395	35
T23	Eq-Unit 396 398	mL
T41	Eq-Temporal-Unit 399 402	min
T42	Allergy 409 416	allergy
T43	Drug 420 435	Zoledronic acid
T44	Drug-Name 420 435	Zoledronic acid
T45	Condition 441 454	hypocalcaemia
T46	Condition-Name 441 454	hypocalcaemia
T47	Drug 490 505	Zoledronic acid
T48	Drug-Name 490 505	Zoledronic acid
T49	Contraindication 465 482	contraindications
A1	Life-Stage-And-Gender-Type T25 female
A2	Life-Stage-And-Gender-Type T26 male
A3	Eq-Operator-Value T27 GT
A4	Eq-Temporal-Unit-Value T28 year
A5	Eq-Operator-Value T30 GTEQ
A6	Eq-Temporal-Unit-Value T32 year
A7	Eq-Temporal-Period-Value T36 past
A8	Eq-Temporal-Period-Value T37 present
A12	Eq-Temporal-Period-Value T52 past
A13	Eq-Temporal-Period-Value T55 anytime
A9	Observation-Type-Value E18 lab
A10	Eq-Operator-Value T21 LT
A11	Eq-Temporal-Unit-Value T41 minute
R1	If-Then Arg1:E1 Arg2:T25
R2	If-Then Arg1:T26 Arg2:E24
R3	Using Arg1:E5 Arg2:E4
R4	Treatment-For Arg1:E5 Arg2:E7
